Bariatric surgery is associated with greater long-term heart risk reduction than weight-loss medications

Mayo Clinic researchers publish critical studies on Alzheimer's, weight loss, early cancer detection

ROCHESTER — In April, several Mayo Clinic research teams published new research that could impact early care for pancreatic cancer and Alzheimer's disease, as well as the long-term impacts of different obesity treatments. Here are those findings: Weight loss surgery vs. GLP-1s A study published in the Annals of Surgery compares the long-term cardiovascular benefits of GLP-1 medications, such as Wegovy and Zepbound, against metabolic and bariatr…

Bariatric surgery is associated with greater long-term heart risk reduction than weight-loss medications

A Mayo Clinic study has found that both metabolic and bariatric surgery and GLP-1 medications improve cardiovascular health in people with obesity, but surgery was associated with significantly greater reductions in long-term cardiovascular risk. The study is a direct comparison of two leading obesity treatments, evaluating how each approach affects the overall risk of cardiovascular disease. The findings are published in Annals of Surgery.

Mayo Clinic study finds bariatric surgery associated with long-term heart risk reduction

Researchers note that longer-term studies are needed to evaluate clinical outcomes such as heart attacks, strokes and survival, as well as the durability of medication-based therapies

MBS is associated with greater long-term heart risk reduction than GLP-1 medications

Both metabolic and bariatric surgery (MBS) and glucagon-like peptide-1 receptor agonist (GLP-1RA) medications improve cardiovascular health in people with obesity, but surgery was associated with significantly greater reductions in long-term cardiovascular risk, according to a study by researchers from the Mayo Clinic.Importantly, researchers say the findings are not about choosing one treatment over another, but about better aligning treatment …

Mayo Clinic Study Reveals Bariatric Surgery Offers Superior Long-Term Heart

A groundbreaking study led by researchers at the Mayo Clinic has delivered new insights into the comparative effectiveness of bariatric surgery and GLP-1 receptor agonist medications, two leading interventions for obesity management, on long-term cardiovascular risk reduction. This comprehensive research, recently published in the prestigious Annals of Surgery, challenges prevailing perceptions about obesity treatment by […]

Mayo Clinic Study Finds Bariatric Surgery Associated with Greater Long-Term Heart Risk Reduction Than Weight-Loss Medications

A Mayo Clinic study found that both metabolic and bariatric surgery and GLP-1 medications improve cardiovascular health in people with obesity, but surgery was associated with significantly greater reductions in long-term cardiovascular risk.